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INTRODUCTION 
Rationale 
Pancreatoduodenectomy (PD)  is still the gold standard of treatment for patients with resectable benign and malignant lesions of the 
head of the pancreas and the periampullary region. Although,  PD is considered a safe operative technique, with 30-days mortality 
rates in specialized, high volume centers currently estimated bellow 3% 1 2,  complications , such as postoperative pancreatic fistula 
(POPF), delayed gastric emptying (DGE) and postpancreatoduodenectomy haemorrhage (POPH), increase the  overall morbidity to 
the rate of  45% , despite the application of  enhanced recovery approaches after surgery 3.  
Given the fact that the frequency of   POPF,  the most notorious postpancreatoduodenectomy complication,  remains an high as  
40% 4 , researchers have focused on factors that may influence this rate, with the pancreatoenteric anastomosis  being one of  them. 
The anastomosis between the pancreatic stump and the GI is regarded as prone to leakage , due to exposure of the suture line to 
pancreatic juice . The two most widely adopted postpancreaticoduodenectomy anastomotic techniques, are the 
pancreatogastrostomy (PG)  and the pancreatojejunostomy (PJ) which combined with anastomotic reinforcing techniques, such as 
glue and intra-ductal stenting, are designed to provide a sealed and stable pancreatoenteric junction. In current literature, a series of 
retrospective and prospective studies5-10 have compared PG and PJ with inconclusive results. Keck et al. 11 ,in a large multicenter 
randomized controlled trial, reported no difference between the two techniques in terms of  clinically significant POPF, which is in 
contrast with results from previous meta-analyses12-14, where  it was suggested that PG was a safer and more effective method of 
reconstruction, with lower rates of POPF and other intra-abdominal complications and shorter length of hospital stay (LΟS).   
Objectives 
In light of these conflicting evidence, we conducted a meta-analysis, in order to provide an up-to-date comparison  of  PG and PJ 
after  PD,for benign or malignant diseases of the head of the pancreas and the periampullary region , in terms of POPF and other 
postoperative complications . 
METHODS 
Study protocol 
The conduction of this meta-analysis was completed according to the PRISMA 15 guidelines and the Cochrane Handbook 
for  Systematic Reviews of  Interventions. The present study was not registrated in any database. 
Primary Endpoint 
The primary endpoint of this study was the rate of overall postoperative pancreatic fistula. POPF was defined by  ISGPF 16 as a 
drain output of any measurable volume of fluid on or after POD 3 with an amylase content  >3 times the serum amylase activity. 
Classification to grade A, B and C is based on the  impact of  POPF to the overall clinical course. 
Secondary Endpoints 
Secondary endpoints included clinically significant POPF (grade B/C), postoperative delayed gastric emptying (DGE) 17, clinically 
significant DGE (grade B/C), postpancreatectomy haemorrhage (PPH)18, clinically significant PPH (grade B/C), biliary fistula, 
intra-abdominal fluid collection, overall morbidity, mortality, reoperation rate, wound infection, intraoperative blood transfusion, 
operative time and the length of hospital stay (LOS).  
Eligibility criteria 
Eligible trials were prospective human studies with a RCT design, comparing PG and PJ after PD for benign or malignant diseases 
of the head of the pancreas and the periampullary region, whose outcome data were reported in English and could be retrieved. 
Excluded studies included those not written in English, with no outcome of interest, with no comparing group , observational, no 
randomized  and  no human studies. Moreover studies reported in the form of  editorials, letters, conference abstracts, expert opinion 
or duplicate studies were excluded.  
Literature search 
A systematic literature search in electronic databases (MEDLINE  and Cochrane Central Register of Controlled Clinical Trials) was 
performed (search date : 20 July 2016) in order to identify the eligible RCTs.   
In order to perform the literature search the following keywords were used :  
 MEDLINE: (Pancreaticoduodenectomy OR Pancreatoduodenectomy OR Whipple OR “pancreatoduodenal resection” OR 
“pancreaticoduodenal resection” OR pancreaticojejunostomy OR pancreatojejunostomy OR “pancreaticoenteric 
anastomosis” OR “pancreatoenteric anastomosis” OR pancreaticogastrostomy OR pancreatogastrostomy OR 
“pancreaticogastric anastomosis” OR “pancreatogastric anastomosis”OR “pancreaticojejunal anastomosis” OR 
“pancreatojejunal anastomosis”) AND ("Clinical Trials as Topic" OR "randomized controlled trial" OR "controlled clinical 
trial" OR randomized OR placebo OR randomly OR trial) 
 Cochrane Central Register of Controlled Clinical Trials (Wiley): (Pancreaticoduodenectomy OR Pancreatoduodenectomy 
OR Whipple OR “pancreatoduodenal resection” OR “pancreaticoduodenal resection” OR pancreaticojejunostomy OR 
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pancreatojejunostomy OR “pancreaticoenteric anastomosis” OR “pancreatoenteric anastomosis” OR 
pancreaticogastrostomy OR pancreatogastrostomy OR “pancreaticogastric anastomosis” OR “pancreatogastric 
anastomosis”OR “pancreaticojejunal anastomosis” OR “pancreatojejunal anastomosis”) 
Study selection and Data collection 
After duplicate removal,  titles and abstracts of the studies were screened according to eligibility criteria. The next step included the 
full text review  of  the articles in order to assess that they are consistent with the inclusion criteria. 
All electronic database search , study selection, data extraction, and methological assessment of the studies were performed  blindly 
and in duplicate by two independent investigators (PK and SE). Disagreements were resolved by mutual revision and discussion,  in 
order to reach a consensus. In case of  not resolving the discrepancies, the opinion of  a third investigator (TA) was considered. 
From all eligible studies the data extracted included : author’s name, study location and year, RCT type,  sample size, the age and  
gender of the participants, primary outcome, follow up duration, overall morbidity, underlying disease, operation type, rate of 
PD/pylorus preserving PD (PPPD), anastomotic technique, operative time, postoperative hospital stay, use of intraductal stent , glue 
and drains , postoperative administration of somatostatin , and information regarding the diameter of pancreatic duct and the texture 
of pancreas. Only results reported in the article of the studies were extracted.  
All studies imported  in this meta-analysis were submitted to rigorous quality and methodological evaluation for bias appraisal 
according to Cochrane’s risk of  bias assessing tool19 . Validity checkpoints included assessment of random sequence allocation, 
allocation concealment, blinding of participants and personnel and blinding of outcome assessment, incomplete outcome data and 
selective reporting. Cohen’s k statistic was also calculated. 
Statistical Analysis 
Data analysis was performed using the Cochrane Collaboration RevMan version 5.3 .Dichotomous variables were reported in the 
form of  Odds Ratio (OR), while for continuous variables Weighted Mean Differences (WMD) were used. Results of  the analyses 
were presented with the corresponding 95% Confidence Interval (95% CI) . 
In the case of continuous variables, if the article did not provide the mean and the Standard Deviation (SD), these were calculated 
from the median and the Interquartile Range (IR), based on the formula by Hojo et al20. More specific, if  the sample size was >25, 
then the mean was considered equal to the median. For sample sizes <70 ,SD was regarded as IR/4. If  the sample size was >70, then 
SD was equal to IR/6. For dichotomous variables, the statistical method used was the Mantel-Haenszel (MH) and for continuous 
variables the Inverse Variance (IV). Both Fixed Effects (FE) and Random Effects (RE) model were calculated. The decision of  
which model to finally estimate was based on the Cochran Q test. If  statistically significant heterogeneity was present (Q t est 
P<0.1) then RE model was applied  . Moreover heterogeneity was quantified with the use of  I2.  The studies were weighted on the 
basis of sample size. Statistical significance was considered at the level of P<0.05. 
Risk of bias across studies 
The funnel plot of the primary outcome was also visually inspected, in order to determine the possible presence of publication bias. 
An Egger’s test was also performed for the primary outcome.  
RESULTS 
Study selection 
From the literature search, 1240 citations (Figure 1) were retrieved, published up to 20 July 2016. After the removing of 236 
duplicate records, the screening of the titles and the abstracts begun. From the 1004 studies submitted to the first phase of the 
screening, 993 were excluded. More specific, 10  were comments or conference abstracts, 5 did not have a RCT design, 5 did not 
have a comparison group, 18 were reviews of the current literature, 20 were meta-analysis, 3 articles were not written in English, 23 
compared different techniques of  PG or PJ instead and 909 were irrelevant to the subject records.  In full text review were 
submitted  11 articles 9 11 21-29.  At this step, 1 trial 9 was rejected due to, a no RCT design. Finally 10 studies 11 21-29 were included in  
qualitative and quantitative analysis.  
Study characteristics 
Table 1 summarizes the characteristics of the included studies. The publication date ranges between 1995 up to 2016. Four studies 
were multi-centered while the other six were single-centered. Fernández-Cruz et al. 24 was the first to adopt the ISGPS definition 
and classification of  POPF. Since then, heterogeneity existed in the definition and diagnosis of POPF. The overall  amount of 
patients included in this meta-analysis is 1629 (Table 2). A total of  826 PGs and 803 PJs were performed . The age of the 
participants extended from 12 to 87 years . Regarding the gender allocation between the two comparison groups, data are shown in 
Table 2. El Nakeeb et al. 
23
 compared  the results of PG and an isolated Roux loop pancreatojejunostomy while  Fernández-Cruz et 
al. 24 , respectively compared PJ and PG with gastric partition. In the rest of the studies, PG was considered the intervention and PJ 
the control. All studies, except Duffas et al.22 had the rate of POPF as primary outcome. Four studies 21 24 26 29  did not report the 
duration of follow up. In the other six studies follow up varied from 30 days to 12 months.  Regarding the underlying disease, 
carcinoma of the pancreatic head was the most frequent (Table 3).The PD and PPPD ratio is shown in Table 3. There was a lack of 
uniformity between the studies regarding the technique of  PG and PJ anastomoses. Both PG and PJ could be performed either in a 
telescoped or a duct-to mucosa manner. Table 4 reports  a summary of  the studies implementing the use of  stents in the pancreatic 
duct, anastomotic glue reinforcement , and the overall drain use.  Postoperative octreotide was administered in 7 studies 21-23 25-28.  
All studies reported data regarding the main pancreatic duct diameter . Similarly, only Topal et al. 27 did not provide the allocation 
of the patients regarding pancreatic texture.  
Risk of bias within studies 
Figure 2 represents a summary of  the included studies quality assessment. More specifically, as shown in Figure 3,  all studies 
included a random sequence  generation procedure in their protocol.  Allocation concealment was also applied in all studies except 
one 29. Only two trials  11 22 reported  the blinding of participants and personnel and the blinding of  outcome assessment. Only  in 
the study of Grendar et al. 26 incomplete outcome data and possible selective reporting was detected. There was almost perfect 
agreement between the two investigators  (Cohen’s k statistic : 82.3% p<0.001) 
Primary Endpoint 
 All the included studies (Figure 4) provided comparison between the two anastomotic techniques regarding POPF. In 
summary, 138 patients from a total of 826 submitted to PG developed POPF, instead of 175 and 803 respectively  in the PJ 
group. Meta-analysis of these data showed a statistically significant (p=0.008) lower ratio of POPF (OR:0.71, 95%CI : 0.55 
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- 0.91) for the PG group. Since there  was no significant heterogeneity between the studies ( Q test P:0.27, I2 :19%(95%CI : 
0-59.8%)), a FE model was applied.    
Secondary Endpoints 
 All ten studies (Figure 6) compared  the two anastomotic techniques regarding the clinically significant  POPF. More 
specifically 108 patients from a total of 826 in the PG group developed clinically significant  POPF, whereas in the PJ 
group the same ratio was 144/803. Meta-analysis of these data showed no statistically significant (p=0.09) difference 
between the two groups regarding clinically significant  POPF (OR:0.70, 95%CI : 0.46 – 1.06). Since there was significant 
heterogeneity between the studies ( Q test P:0.04, I2 :48%(95%CI : 0-75%)), a RE model was applied.    
 Eight studies (Figure 7) provided data for DGE. Meta-analysis of the data showed no statistically significant (p=0.75) 
difference between the two groups regarding DGE (OR:1.08, 95%CI : 0.68 – 1.70). Heterogeneity was significant between 
the studies ( Q test P:0.04, I2 :53%(95%CI : 0-78.9%)), so a RE model was used.  
 Eight studies (Figure 8) provided data for clinically significant DGE. Meta-analysis of the data showed no statistically 
significant (p=0.93) difference between the two groups regarding clinically significant DGE (OR:0.98, 95%CI : 0.59 – 
1.63). Heterogeneity was significant between the studies ( Q test P:0.03, I2 :55%(95%CI : 1.7%-79.8%)), so a random 
effects model was used.  
 Eight studies (Figure 9) provided data for PPH. Meta-analysis of the data showed statistically significant (p=0.02) 
difference between the two groups regarding POPH (OR:1.52, 95%CI : 1.08 – 2.14) in favor of  PJ group . Heterogeneity 
was not significant between the studies ( Q test P:0.85, I2 :0%(95%CI : 0-80.3%)), so a FE model was used.  
 Eight studies (Figure 10) provided data for clinically significant PPH. Meta-analysis of the data showed no statistically 
significant (p=0.10) difference between the two groups regarding clinically significant POPH (OR:1.35, 95%CI : 0.95 – 
1.93). Heterogeneity was not significant between the studies ( Q test P:0.96, I2 :0%(95%CI : 0-75.9%)), so a FE  model was 
used.  
 Seven studies (Figure 11) provided data for biliary fistula. Meta-analysis of the data showed no statistically significant 
(p=0.08) difference between the two groups regarding biliary fistula (OR:0.58 , 95%CI : 0.31 – 1.06). Heterogeneity was 
not significant between the studies ( Q test P:0.14, I2 :38%(95%CI : 0-73.7%)), so a FE  model was used.  
 Nine studies (Figure 12) provided data for intra-abdominal fluid collection. Meta-analysis of the data showed no 
statistically significant (p=0.06) difference between the two groups regarding intra-abdominal fluid collection (OR:0.64, 
95%CI : 0.40 – 1.02). Heterogeneity was significant between the studies ( Q test P:0.07, I2 :45%(95%CI : 0-74.6%)), so a 
RE  model was used.  
 Eight studies (Figure 13) provided data for morbidity. Meta-analysis of the data showed no statistically significant (p=0.82) 
difference between the two groups regarding morbidity (OR:0.97, 95%CI : 0.77 – 1.23). Heterogeneity was not significant 
between the studies ( Q test P:0.21, I2 :28%(95%CI : 0-67.5%)), so a FE  model was used.  
 Ten studies (Figure 14) provided data for mortality. Meta-analysis of the data showed no statistically significant (p=0.94) 
difference between the two groups regarding mortality (OR:0.98, 95%CI : 0.60 – 1.61). Heterogeneity was not significant 
between the studies ( Q test P:0.94, I2 :0%(95%CI : 0-76.8%)), so a FE  model was used.  
 Eight studies (Figure 15) provided data for reoperation rate. Meta-analysis of the data showed no statistically significant 
(p=0.33) difference between the two groups regarding reoperation rate (OR:0.84, 95%CI : 0.59 – 1.20). Heterogeneity was 
not  significant between the studies ( Q test P:0.79, I2 :0%(95%CI : 0-83%)), so a FE  model was used.  
 Four studies (Figure 16) provided data for wound infection. Meta-analysis of the data showed no statistically significant 
(p=0.77) difference between the two groups regarding wound infection (OR:1.08, 95%CI : 0.66– 1.76). Heterogeneity was 
not significant between the studies ( Q test P:0.86, I2 :0%(95%CI : 0-90%)), so a FE  model was used.  
 Six studies (Figure 17) provided data for blood transfusion. Meta-analysis of the data showed no statistically significant 
(p=0.86) difference between the two groups regarding blood transfusion  (OR:1.03, 95%CI : 0.72 – 1.47). Heterogeneity 
was not  significant between the studies ( Q test P:0.39, I2 :5%(95%CI : 0-91.4%)), so a FE  model was used.  
 Ten studies (Figure 18) provided data for operative time. Meta-analysis of the data showed no statistically significant 
(p=0.41) difference between the two groups regarding operative time (MWD:-5.73, 95%CI : -19.3, 7.85). Heterogeneity 
was significant between the studies ( Q test P:<0.001, I2 :97%(95%CI : 0-98.1%)), so a RE  model was used.  
 Ten studies (Figure 19) provided data for LOS. Meta-analysis of the data showed no statistically significant (p=0.33) 
difference between the two groups LOS (MWD:-0.74, 95%CI : -2.24, 0.76). Heterogeneity was significant between the 
studies ( Q test P:<0.001, I2 :91%(95%CI : 0-94.6%)), so a RE  model was used.  
 
Risk of bias across studies 
Funnel plot of primary outcome (POPF) is shown in Figure 5. No study resides beyond the limits of 95% CI . Egger’s test showed 
that there was no statistically significant publication bias (p=0.976). 
DISCUSSION 
Summary of evidence 
Pancreaticoduodenectomy remains the most widely used surgical modality for the treatment of  pancreatic head and periampullary 
tumors. Failure of the pancreatic anastomosis resulting in POPF has been identified as one of the most important  factor of  
postoperative morbidity. It must also be mentioned that POPF is assumed to have a close relationship with other post PD 
complications, such as IAC, DGE and PPH 30 31.  As a result, surgeons, in an attempt to minimize post PD complications have 
meticulously compared the available anastomotic techniques. 
In our study, after a systematic literature search,  a meta-analysis of  available RCTs was performed. In the qualitative and 
quantitative analysis, 10 studies with a total of  1629 patients were included. Regarding the primary outcome, PG was superior to PJ, 
thus, presenting lower rates of overall POPF. However this result was not confirmed when the two techniques were compared on the 
basis of  clinically significant POPF, where no statistically significant difference was found.  Heterogeneity in clinically significant 
POPF could possibly be the result of non uniformity in the definition of POPF. Although the included studies after 2005 were 
consistent with the 2005 ISGPS POPF definition, the remaining , defined POPF in an inconsistent way.  DGE and clinically 
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significant DGE were found to have no difference between PG and PJ, with a high level of heterogeneity though. As the operation 
type was not determined in most eligible studies, surgeons performed either PD or PPPD. The above mentioned heterogeneity could 
be explained  in the light of  lack of stratification regarding the operation type. Respectively, results from pooled data showed a 
lower rate of PPH for PJ, but no difference for clinically significant PPH. Heterogeneity for both of them was 0%, increasing thus 
the validity of these findings. The rate of  biliary fistula and the intra abdominal fluid collection  was not significantly different 
between PG and PJ, which diverges from the results of previous studies32-35, due to inclusion of  the recent RCTs 11 26. Moreover, 
overall postoperative morbidity for both techniques was estimated at the level of 49%, complying with current literature 4.  
Similarly, no difference was found in terms of mortality, reoperation rate, wound infection and perioperative blood transfusion. 
Finally, PG was not superior to PJ in terms of operation time and LOS. Heterogeneity was significantly high in these comparisons,  
possibly due to the approximate calculation of the mean and SD . 
It is common knowledge between surgeons, that risk factors for development of POPF are the age, gender of the patient, 
preoperative jaundice and malnutrition, underlying pathology, pancreatic texture and pancreatic duct size, operative time, resection 
type, anastomotic technique, and intraoperative blood loss 36. El Nakeeb et al.31 , however, in a retrospective study of 471 patients, 
suggested that risk factors for POPF include the cirrhotic liver, BMI, soft pancreas, pancreatic diameter <3mm, and pancreatic duct 
near the posterior border. This is inconsistent with the results from our meta-analysis, were PG was proven superior to PJ for overall 
POPF, mainly due to the imbalance of  the two groups (PG: 424, PJ:46) in the above mentioned study. 
The superiority of PG over PJ in terms of POPF can be justified by some theoretical advantages. Firstly, due to the fact that the 
posterior wall of the stomach lies just above the pancreatic remnant, the tension between the stomach and the pancreatic stump is 
minimized. Secondly, the acidic gastric content prevent the activation of pancreatic enzymes and consequently the the anastomotic 
lysis.  Moreover, compared to a jejunum loop, the stomach wall is thicker, thus stabilizing the anastomosis. Finally, the abundant 
stomach wall vascularization, decreases the chance of an anstomotic ischaemia. This may also be the reason of increased post PD 
PPH in the PG group, rendering perioperative meticulous haemostasis of  utmost importance.  
As far as postoperative endocrine and exocrine pancreatic function is concerned, data are scarce and inconsistent, thus making 
further analysis very difficult . Figueras et al. 25 reported a higher stool elastase level and significant lesser weight loss in the PG 
group. Comparing PG and IRPJ, El Nakeeb et al. 23, concluded that postoperative steatorrhea and need  for pancreatic enzyme 
supplements was higher in the PG group, while post PD serum albumin was in a lower level in patients submitted to PG. In the most 
recent RCT, Keck et al. 11 found that the need for oral enzyme supplements in six months after surgery was lower in the PG group, 
with the rate of reported steatorrhea further decreasing after 12 months. 
Our meta-analysis provides an up-to-date pooled , published only data,  estimation of the rate of POPF and other postoperative 
complications between the two most popular anastomotic technique. Compared to other recent studies 12 37, it reports results not only 
in  overall morbidity, but also in clinically significant complications, such as DGE and PPH.   
Limitations 
Several limitations should be taken into account before appraising the results of this meta-analysis. First of all, there is a diversity in 
the  POPF definition among the included studies. It must be noted, though, that all studies after 2005 use the ISGPS definition. The 
included trials have also incorporotated, both PD and PPPD in their study groups and there was ,also, no stratification on the basis of 
the underlying pathology. Moreover, a lack of uniformity exists, regarding the surgical anastomotic technique  that may possibly 
result in biased results. Factors, like the texture of pancreas and the pancreatic duct diameter might also influence the results.   
Another source of  bias could be the perioperative use of glue and stents and the postoperative administration of somatostatin ,since 
not all studies reported these information. Finally, another factor that contributes in heterogeneity is the surgical experience in the 
applied anastomotic technique.  
Conclusions 
The present meta-analysis of RCTs, demonstrates that, PG has lower overall incidence of POPF and higher rate of  PPH against PJ. 
There was no difference between the two anastomotic techniques regarding clinically significant POPF ,DGE, clinically significant 
DGE , clinically significant PPH , biliary fistula, intra-abdominal fluid collection, overall morbidity, mortality, reoperation rate, 
wound infection, intraoperative blood transfusion, operative time and LOS. Given several limitations, more large scale high quality 
RCTs are required for the effect of the anastomotic technique on the incidence of POPF to be clarified.  
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APPENDIX 
Tables 
PMID First 
author 
Country Publication 
year 
RCT type POPF definition 
26135690 Keck GERMANY 2016 multicenter ,randomized, 
controlled, observer- and patient-
blinded trial 
ISGPS (grade B/C) 
25799130 Grendar CANADA 2015 single­center randomized 
controlled trial 
Radiologically proven 
anastomotic leak or 
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continued drainage of 
lipase-rich fluid on PoD 
10. Classification by 
ISGPS 
24467711 El Nakeeb EGYPT 2014 single center, prospective 
randomized study 
ISGPS (grades A/B/C) 
24264781 Figueras SPAIN 2013 multicenter, prospective 
randomized study 
ISGPS(grade B/C) 
23643139 Topal BELGIUM 2013 multicentre, randomised 
superiority trial 
ISGPS(grade B/C) 
22744638 Wellner GERMANY 2012 single center, open, randomized 
controlled study 
ISGPS(grade B/C) 
19092337 Fernández-
Cruz 
SPAIN 2008 single center ,prospective 
randomized study 
ISGPS(grade B/C) 
16327486 Bassi ITALY 2005 single center ,prospective and 
randomized  study 
Any clinical significant 
output of fluid, rich in 
amylase, confirmed by 
fistulography 
15910726 Duffas FRANCE 2005 multicenter, single blind, 
controlled randomized, trial 
Fluid obtained through 
drains or percutaneous 
aspiration, containing at 
least 4 times normal serum 
values of amylase for 3 
days or as anastomotic 
leaks shown by 
fistulography 
7574936 Yeo USA 1995 single center , prospective 
randomized trial 
Drainage of greater than 
50 mL of amylase rich 
fluid (greater than 
threefold elevation above 
upper limit of normal in 
serum) through the 
operatively placed drains 
on or after 
Table 1. Included studies 
 
First 
author 
Sample 
size 
Age Gender (M/F) Intervention Comparator Primary 
outcome 
Follow up Morbidity   
PG PJ PG PJ PG PJ PG PJ 
Keck 17
1 
14
9 
68(35
-86) 
66(
29-
87) 
95/76 93/5
6 
PG PJ clinically 
relevant 
POPF,gra
de B or C 
12 months N/A 
Grendar 48 50 63.6 ± 
13.1 
68.
1 ± 
10.
7 
20/28 29/2
1 
PG PJ rate of 
pancreati
c 
anastomo
tic 
leak/fistul
a 
N/A 29 24 
El Nakeeb 45 45 58 
(12–
73) 
54 
(15
–
73) 
23/22 27/1
8 
PG isolated 
Roux loop 
pancreaticoje
junostomy 
rate of 
POPF 
12 months 17 14 
Figueras 65 58 67 
(35–
80) 
65.
5 
(42
–
80) 
44/21 37/2
1 
PG PJ rate of 
POPF 
6 months 41 38 
Topal 16
2 
16
7 
67.0 
(60.6–
73.5) 
66.
1 
(59.
4–
74.
6) 
100/6
2 
91/7
6 
PG PJ clinically 
relevant 
POPF,gra
de B or C 
2 months 100 99 
Wellner 59 57 67 
(34–
64 
(23
27/32 29/2
8 
PG PJ clinically 
relevant 
90 days N/A 
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84) –
81) 
POPF,gra
de B or C 
Fernández
-Cruz 
53 55 63 ± 
13 
63 
± 
14 
29/24 38/1
7 
PG with 
gastric 
partition 
PJ rate of 
POPF 
N/A 12 24 
Bassi 69 82 59.3 
(58.2–
60.4) 
55.
5(5
4.5
–
56.
6) 
44/25 35/3
3 
PG PJ rate of 
POPF 
N/A 20 32 
Duffas 81 68 58.2 ± 
11 
58.
6 ± 
12 
51/30 35/3
3 
PG PJ rate of 
one or 
more 
postopera
tive IACs 
30 days 37 32 
Yeo 73 72 61.5 ± 
1.7 
62.
4 ± 
1.4 
33/40 38/3
4 
PG PJ rate of 
POPF 
N/A 36 31 
Table 2. Study characteristics 
 
First 
author 
Disease 
(PDAC/DD/A
MP/DBD/OT
HER 
Opera
tion 
type 
pd/pppd Technique Operative time Postoperative 
hospital stay 
PG PJ PG PJ PG PJ PG PJ PG PJ 
Keck 104/-
/10/-
/14 
98/-
/11/-
/14 
pd or 
pppd 
37/
134 
28/
12
1 
dunking , 
pursestring or 
interrupted or 
combination 
suture 
duct to mucosa 
or dunking, 
running or 
interrupted or 
combination 
suture 
332(16
5–600) 
337(16
5–565) 
15(5–
208) 
16(3–
129) 
Grendar N/A pd or 
pppd 
N/A posterior 
gastrostomy,2 
layers 
anastomosis 
2-layer end-to-
side 
anastomosis 
349 ± 
70 
356 ± 
65 
17.4 ± 
11.6 
14.0 ± 
5.4 
El Nakeeb 26/2/1
7/0/0 
20/4/
19/2/
0 
pd 45/
0 
45/
0 
posterior 
gastrostomy,2 
layers 
anastomosis 
two layers end-
to-side  
pancreaticojejun
ostomy 
300 
(210–
420) 
320 
(240–
480) 
9 (4–
34) 
8 (5–
41) 
Figueras 33/6/8
/8/10 
29/10
/7/3/1
9 
pd or 
pppd 
35/
30 
30/
28 
posterior 
gastrostomy 
double-layer 
invaginated 
duct-to-mucosa 
pancreaticojejun
ostomy 
330 
(235–
620) 
305 
(240–
510) 
12 (1–
52) 
15,5 
(6–55) 
Topal 98/11/
23/28/
2 
107/1
4/28/
15/3 
pd or 
pppd 
65/
98 
65/
10
2 
end-to-side 
telescoped 
antecolic 
posterior 
gastrostomy 
end-to-side 
telescoped 
pancreaticojejun
ostomy 
250 
(210–
320) 
250 
(210–
310) 
19 (14–
25) 
18 (14–
25) 
Wellner 26/3/9
/2/8 
30/2/
7/2/1
0 
pd or 
pppd 
7/5
2 
2/5
5 
invagination, 
posterior 
pancreatogastros
tomy with 
pursestring 
suture 
duct-to mucosa 
pancreaticojejun
ostomy 
404 
(280–
629) 
443 
(230–
683) 
15 (7–
135) 
17 (10–
60) 
Fernánde
z-Cruz 
26/1/1
2/8/9 
28/1/
10/7/
9 
pppd 0/5
3 
0/5
5 
End-to-side duct-
to- mucosa  
pancreatogastros
tomy 
end-to-side duct 
mucosa 
anastomosis 
PPPD-PJ 
300 ± 
50 
310 ± 
60 
12 ±2 16 ± 3 
Bassi 32/1/1
3/1/22 
28/1/
11/2/
40 
pd or 
pppd 
3/6
6 
12/
70 
posterior single 
layer  telescoped 
gastrostomy 
single-layer 
pancreaticojejun
al or duct to 
mucosa 
337.2 
(336.1–
338.2) 
359.3 
(352.9–
354.9) 
14.2 
(13.1–
15.3) 
15.4 
(14.3–
16.5 ) 
Duffas 34/3/1
7/8/19 
25/3/
19/11
/10 
pd or 
pppd 
63/
18 
50/
18 
depending 
surgeon's  
preference 
depending 
surgeon's  
preference 
6.5 ± 
2.6 (h) 
6.4 ± 
2.2 (h) 
20 (1–
98) 
21 (7–
97) 
Yeo 40/4/7 40/5/ pd or 13/ 13/ posterior end -to- end or 7.4 ± 7.2 ± 17.1 ± 17.7 ± 
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/6/16 11/7/
9 
pppd 60 59 gastrostomy end-to-side  
pancreaticojejun
ostomy 
0.2(h) 0.2(h) 1.6 1.5 
Table 3. Operative characteristics 
 
First 
author 
Stent Postoperative 
octreotide 
Anastomotic 
glue 
reinforcement 
Drains Pancreatic 
parenchyma 
(soft/hard) 
Pancreatic duct 
diameter 
PG PJ PG PJ PG PJ PG PJ PG PJ PG PJ 
Keck N/A N/A N/A  N/A 95/66 83/62   94 
(<3mm) 
78 
Grendar 10 39 42 39 N/A 38 44 25/23 18/32 3.8 ± 2.4 
(mm) 
4.3 ± 2.6 
El 
Nakeeb 
0 0 45 45 N/A N/A 26/19 22/23   22 
(<3mm) 
21 
Figueras N/A 65 58 N/A 65 58 34/31 33/25 4 (1–15) 
(mm) 
4 (1–11) 
Topal 0 0 162 167 0 0 162 167 N/A   98 
(<3mm) 
102 
Wellner 0 57 22 13 N/A 59 57 35/23 29/28   26 
(<3mm) 
18 
Fernánde
z-Cruz 
53 55 0 0 N/A 53 55 24/29 25/30 3.0 ± 1.7 
(mm) 
3.0  ±1.6 
Bassi 0 0 69 82 N/A 69 82 69/0 82/0 <5 mm 
Duffas 15 15 22 22 17 1
2 
81 68 49/32 41/27 32 
(<3mm) 
31 
Yeo 0 0 0 0 0 0 73 72 16/21 17/28 3.4 ± 0.2 
(mm) 
2.9 ± 0.2 
Table 4. Intraoperative characteristics 
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Figure 1. Study flow diagram 
 
 
Figure 2. Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included 
studies. 
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Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study. 
 
 
Figure 4. Postoperative pancreatic fistula 
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Figure 5. Funnel plot of comparison: Postoperative pancreatic fistula. 
 
 
Figure 6. Clinically significant postoperative pancreatic fistula 
 
 
Figure 7. Delayed gastric emptying. 
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Figure 8. Clinically significant delayed gastric emptying. 
 
 
Figure 9. Postpancreatectomy haemorrhage. 
 
 
Figure 10. Clinically significant postpancreatectomy haemorrhage. 
 
 
Figure 11. Biliary fistula. 
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Figure 12. Intra-abdominal fluid collection. 
 
 
Figure 13. Morbidity. 
 
 
Figure 14. Mortality. 
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Figure 15. Reoperation. 
 
 
Figure 16. Wound Infection. 
 
 
Figure 17. Blood transfusion. 
 
 
Figure 18. Operative time. 
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Figure 19. Length of hospital stay. 
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